0001209191-23-010574.txt : 20230217
0001209191-23-010574.hdr.sgml : 20230217
20230217161610
ACCESSION NUMBER: 0001209191-23-010574
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Al-Wakeel Yasir B.
CENTRAL INDEX KEY: 0001650691
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39592
FILM NUMBER: 23642765
MAIL ADDRESS:
STREET 1: MERRIMACK PHARMACEUTICALS, INC.
STREET 2: ONE KENDALL SQUARE, SUITE B7201
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kronos Bio, Inc.
CENTRAL INDEX KEY: 0001741830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 400
CITY: SAN MATEO
STATE: CA
ZIP: 94402
BUSINESS PHONE: (650) 781-5200
MAIL ADDRESS:
STREET 1: 1300 S. EL CAMINO REAL
STREET 2: SUITE 400
CITY: SAN MATEO
STATE: CA
ZIP: 94402
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-15
0
0001741830
Kronos Bio, Inc.
KRON
0001650691
Al-Wakeel Yasir B.
C/O KRONOS BIO, INC.
1300 SO. EL CAMINO REAL, SUITE 300
SAN MATEO
CA
94402
0
1
0
0
Chief Financial Officer
Common Stock
2023-02-15
4
A
0
138911
0.00
A
364745
D
Employee Stock Option (Right to Buy)
2.09
2023-02-15
4
A
0
208367
0.00
A
2033-02-14
Common Stock
208367
208367
D
Includes an aggregate of 8,993 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on the following dates: 1,478 shares on June 30, 2021, 1,039 shares on December 31, 2021 and 6,476 shares on December 30, 2022.
1/48th of the shares subject to the option vest in equal monthly installments over a four year period following the date of grant.
/s/ Allison Frisbee, Attorney-in-Fact
2023-02-17